Figure 2.
Recurrent genomic MCL alterations identified using WGS/WES analysis. The frequencies displayed correspond to the studies detailed in Table 1. (A) Illustrates the CNA observed (overall frequency ≥2%) in 202 patients with MCL. The frequency of genomic alterations highlighted with an asterisk “∗” is based only on the Nadeu et al5 publication. (B) CNA identified in Nadeu et al5 categorized by MCL subtype. (C) Single nucleotide variants (SNVs) and insertions and deletions (indels) with overall frequency ≥2%, identified in 432 patients with MCL. (D) SNVs and indels, identified in Nadeu et al5 and categorized by MCL subtype. Variants with an overall frequency ≥2% in at least 1 of the MCL subtypes are displayed.

Recurrent genomic MCL alterations identified using WGS/WES analysis. The frequencies displayed correspond to the studies detailed in Table 1. (A) Illustrates the CNA observed (overall frequency ≥2%) in 202 patients with MCL. The frequency of genomic alterations highlighted with an asterisk “∗” is based only on the Nadeu et al5 publication. (B) CNA identified in Nadeu et al5 categorized by MCL subtype. (C) Single nucleotide variants (SNVs) and insertions and deletions (indels) with overall frequency ≥2%, identified in 432 patients with MCL. (D) SNVs and indels, identified in Nadeu et al5 and categorized by MCL subtype. Variants with an overall frequency ≥2% in at least 1 of the MCL subtypes are displayed.

Close Modal

or Create an Account

Close Modal
Close Modal